Spots Global Cancer Trial Database for combination of tremelimumab and durvalumab
Every month we try and update this database with for combination of tremelimumab and durvalumab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) | NCT02821754 | Biliary Tract N... Liver Cancer Hepatocellular ... Cholangiocarcin... Bile Duct Cance... | Durvalumab Tremelimumab Trans-arterial ... Radiofrequency ... Cryoablation | 18 Years - | National Institutes of Health Clinical Center (CC) |